Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
Wyatt B Messenger, Robert M Beardsle, Christina J FlaxelCasey Eye Institute, Oregon Health and Science University, Portland, OR, USAAbstract: Diabetic macular edema (DME) remains one of the leading causes of moderate to severe vision loss. Although laser
Messenger WB, Beardsley RM, Flaxel CJ
doaj
Effect of dehydroepiandroesterone and triamcinolone acetonide on 3T3-L1 cell line
Gisela Gutiérrez-Iglesias +9 more
openalex +1 more source
Keratoprosthesis, silicone oil placement, and fluocinolone acetonide implant for treatment of uveitis-associated hypotony and keratopathy [PDF]
Arman Mosenia +3 more
openalex +1 more source
Reply to Hall J: “Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population” [PDF]
Baldo Scassellati Sforzolini
openalex +1 more source
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study [PDF]
Jost B. Jonas +4 more
openalex +1 more source
Continuous glucose monitoring metrics following sub-Tenon’s injection of triamcinolone acetonide for diabetic macular edema [PDF]
Rei Sotani-Ogawa +6 more
openalex +1 more source
Update on corticosteroids for diabetic macular edema
Stephen G Schwartz,1 Ingrid U Scott,2,3 Michael W Stewart,4 Harry W Flynn Jr1 1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, 2Department of Ophthalmology, 3Department of Public Health
Schwartz SG +3 more
doaj
Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis [PDF]
Francesco Zulian
openalex +1 more source

